Supplier · public contract awards
Outlook Therapeutics Limited public contracts.
Outlook Therapeutics Limited has won 12 public contracts in 2025 from 4 public buyers in Germany. Its most frequent buyer is IKK classic (3 awards).
12Contracts won
4Public buyers
1Country
Jul 2025Latest award
Latest contracts won
Németország – Gyógyszerészeti termékek – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu Bevacizumab gamma (Lytenava)
Awarded by GWQ ServicePlus AG · Germany
4 Jul 2025Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 bzw. § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Lyte
Awarded by DAK-Gesundheit · Germany
24 Jun 2025Awarded
Németország – Gyógyszerészeti termékek – Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK
Awarded by IKK classic · Germany
20 Jun 2025Awarded
Németország – Gyógyszerészeti termékek – Vereinbarung nach § 130a Abs. 8 SGB V i. V. m. § 130c Abs. 1 SGB V zum Wirkstoff Bevacizumab gamma (Lytenava™
Awarded by AOK Baden-Württemberg · Germany
22 May 2025Awarded
Contracts won by year
Typical contract size on TED
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against Outlook Therapeutics Limited?
askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
Start bidding See open tenders